Skeletal muscles account for 60%–70% of the insulin-stimulated glucose uptake and are described as a primary determinant of metabolic disorders (Turpin et al., 2009; Montgomery et al., 2017; Mikovic and Lamon, 2018). The gene discussed is INS; the disease is Other metabolic disease.